Abstract
Vitamin D deficiency is a prominent feature of chronic kidney disease (CKD) even in its early stages. While vitamin D deficiency leads to mineral imbalance and bone problems in CDK patients, it also accelerates the progression of kidney disease. Ever since the observation that vitamin D analogs reduce proteinuria in CKD patients, it has been postulated that podocytes are major target of the reno-protective action of vitamin D. Recent large randomized clinical trials have confirmed the potent anti-proteinuric activity of vitamin D therapy. Studies from various animal models of kidney disease have demonstrated that vitamin D prevents podocyte injury and cell loss, promotes the expression of slit diaphragm proteins and maintains the integrity of the glomerular filtration barrier. Emerging experimental data suggest that vitamin D may protect podocytes by targeting multiple pathways, including the renin-angiotensin system, Wnt/β-catenin pathway and pro-apoptotic pathway.
Keywords: Vitamin D, Vitamin D analog, Podocyte, Diabetic nephropathy, Chronic kidney disease, 7-dehydrocholesterol, D 25-hydroxylase, 25-hydroxyvitamin, D3 (25OHD3), hydroxyvitamin D 1-hydroxylase (CYP27B1), parathyroid hormone, fibroblast growth factor (FGF), CYP24, rular filtration rate (GFR), DBP-25OHD3, receptor (VDR), PCNA, desmin, streptozotocin (STZ), actinin-4, losartan, Wnt/-catenin pathway, apoptotic pathway, hyper-glycemia, NF-B pathway, hyperreninemia, catenin, adriamycin injury, ameliorates podocyte lesio, p38, keratinocytes, Podocyte gene expression
Current Diabetes Reviews
Title: Podocytes as Target of Vitamin D
Volume: 7 Issue: 1
Author(s): Yan C. Li
Affiliation:
Keywords: Vitamin D, Vitamin D analog, Podocyte, Diabetic nephropathy, Chronic kidney disease, 7-dehydrocholesterol, D 25-hydroxylase, 25-hydroxyvitamin, D3 (25OHD3), hydroxyvitamin D 1-hydroxylase (CYP27B1), parathyroid hormone, fibroblast growth factor (FGF), CYP24, rular filtration rate (GFR), DBP-25OHD3, receptor (VDR), PCNA, desmin, streptozotocin (STZ), actinin-4, losartan, Wnt/-catenin pathway, apoptotic pathway, hyper-glycemia, NF-B pathway, hyperreninemia, catenin, adriamycin injury, ameliorates podocyte lesio, p38, keratinocytes, Podocyte gene expression
Abstract: Vitamin D deficiency is a prominent feature of chronic kidney disease (CKD) even in its early stages. While vitamin D deficiency leads to mineral imbalance and bone problems in CDK patients, it also accelerates the progression of kidney disease. Ever since the observation that vitamin D analogs reduce proteinuria in CKD patients, it has been postulated that podocytes are major target of the reno-protective action of vitamin D. Recent large randomized clinical trials have confirmed the potent anti-proteinuric activity of vitamin D therapy. Studies from various animal models of kidney disease have demonstrated that vitamin D prevents podocyte injury and cell loss, promotes the expression of slit diaphragm proteins and maintains the integrity of the glomerular filtration barrier. Emerging experimental data suggest that vitamin D may protect podocytes by targeting multiple pathways, including the renin-angiotensin system, Wnt/β-catenin pathway and pro-apoptotic pathway.
Export Options
About this article
Cite this article as:
C. Li Yan, Podocytes as Target of Vitamin D, Current Diabetes Reviews 2011; 7 (1) . https://dx.doi.org/10.2174/157339911794273964
DOI https://dx.doi.org/10.2174/157339911794273964 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
Call for Papers in Thematic Issues
Advancing Diabetic Wound Healing: Mechanisms and Interventions
In recent years, diabetic wounds have become a global health concern with the increase in the incidence of diabetes. Diabetic wounds are a kind of chronic and refractory ulcer. It is generally due to the microcirculatory disturbances and the reduced levels of endogenous growth factors. Delayed cutaneous wound healing is ...read more
Oxidative and inflammatory responses in the development of secondary diabetic complications
Diabetes, along with its associated secondary complications, represents a significant global health challenge, contributing significantly to morbidity and mortality. Unhealthy lifestyle habits, reduced physical activity, environmental pollutants, and stress are pivotal factors in the onset of diabetes, particularly type-2 diabetes. Poorly managed hyperglycemia can lead to various complications, including neuropathy, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Validated RP-HPLC Method for Simultaneous Estimation of Valsartan & Gliclazide in Bulk and Dosage Forms
Current Pharmaceutical Analysis Islet Amyloid Polypeptide (IAPP): A Second Amyloid in Alzheimer's Disease
Current Alzheimer Research Should Percutaneous Coronary Intervention be the Standard Treatment Strategy for Significant Coronary Artery Disease in all Octogenarians?
Current Cardiology Reviews Genetic Studies of Type 2 Diabetes in South Asians: A Systematic Overview
Current Diabetes Reviews The Bioenergetics of Isolated Mitochondria from Different Animal Models for Diabetes
Current Diabetes Reviews Phase 4 Studies in Heart Failure - What is Done and What is Needed?
Current Cardiology Reviews Human Urotensin II and Metabolic Syndrome
Vascular Disease Prevention (Discontinued) Non-dipping Status in Arterial Hypertension: An Overview
Current Vascular Pharmacology Oxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus
Cardiovascular & Hematological Agents in Medicinal Chemistry Role of Advanced Glycation End Products in Diabetic Neuropathy
Current Pharmaceutical Design The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Antioxidant Capacities of Flavones and Benefits in Oxidative-Stress Related Diseases
Current Topics in Medicinal Chemistry Diabetes, Cognitive Function, and the Blood-Brain Barrier
Current Pharmaceutical Design Gastric Bypass and Diabetes: Past, Present and Future
Current Diabetes Reviews Inhibitory Role of Resveratrol in the Development of Profibrogenesis and Fibrosis Mechanisms
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial [Hot topic: Transportalopathy and Vascular Cell Dysfunction (Guest Editor: Luis Sobrevia)]
Current Vascular Pharmacology The Versatile Stress Protein Mortalin as a Chaperone Therapeutic Agent
Protein & Peptide Letters Cardiovascular Effects of Losartan and Its Relevant Clinical Application
Current Medicinal Chemistry Genome Study of Kidney Disease in the Age of Post Genome-Sequencing
Endocrine, Metabolic & Immune Disorders - Drug Targets Origin and Biological Significance of Shed-Membrane Microparticles
Endocrine, Metabolic & Immune Disorders - Drug Targets